Popular on TelAve
- Bald Guy Greetings Launches Bold New Postcard Line Celebrating Over-the Top (and Often Delusional) Confidence - 220
- People & Stories/Gente y Cuentos Announces New Board Leadership & Corporate Partnership Initiative - 164
- Electives Appoints DraftKings' CPO Linda Aiello to Board Amid Record Quarter - 158
- Mensa identifies best board games of 2025 - 131
- Village Vapes and Cooking 4 Autism Announce Inaugural Partnership at MEGA 420 EVENT
- Is Billboard Advertising Still Effective in 2025?
- K2 Integrity Expands Cyber and AI Resilience Leadership with Jamar Haywood Appointment
- QRYIX Issues Public Statement: Actively Addressing False Reviews and Upholding Business Integrity
- Portland Hosts Mensa's 2025 Mind Games®
- Total Communication Solutions Joins Zoom's Partner Delivery Program for Contact Center
Similar on TelAve
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- Sahit Muja Launches Trillion-Dollar Green Revolution with 10 Groundbreaking Cryptos
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
TelAve News/10862181
NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether West and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until July 7, 2025 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired West securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
More on TelAve News
[Click here for information about joining the class action]
On February 13, 2025, West issued weak 2025 revenue and earnings forecasts. The Company attributed the disappointing guidance in part to headwinds affecting its Contract Manufacturing segment, including the loss of two major continuous glucose monitoring customers that had begun transitioning to in-house manufacturing of next-generation devices after West "made the decision not to participate going forward as our financial thresholds cannot be achieved." West also revealed that its SmartDose wearable injector devices would be "margin dilutive" in 2025 and that it would be "taking steps to improve [its SmartDose] economics, and all options are on the table."
On this news, West's stock price fell $123.17 per share, or 38.2%, to close at $199.11 per share on February 13, 2025.
More on TelAve News
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
The class action concerns whether West and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until July 7, 2025 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired West securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
More on TelAve News
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- Whistleblower Seeks SEC and Shareholder Review of Cogent Communications' 2003 Acquisition of FNSI
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
[Click here for information about joining the class action]
On February 13, 2025, West issued weak 2025 revenue and earnings forecasts. The Company attributed the disappointing guidance in part to headwinds affecting its Contract Manufacturing segment, including the loss of two major continuous glucose monitoring customers that had begun transitioning to in-house manufacturing of next-generation devices after West "made the decision not to participate going forward as our financial thresholds cannot be achieved." West also revealed that its SmartDose wearable injector devices would be "margin dilutive" in 2025 and that it would be "taking steps to improve [its SmartDose] economics, and all options are on the table."
On this news, West's stock price fell $123.17 per share, or 38.2%, to close at $199.11 per share on February 13, 2025.
More on TelAve News
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
0 Comments
Latest on TelAve News
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- Transportation and Communications Sector SG&A Benchmarks 2025 edition released
- Events by Dubsdread Expands Services to The Venue at Lake Lily
- London Gala Emphasizes Trade, FDI and Ongoing Cooperation
- Sahit Muja Launches Trillion-Dollar Green Revolution with 10 Groundbreaking Cryptos
- Free and Low-Cost Dental Care Now Available in London Through the Canadian Dental Care Plan (CDCP)
- Garden State Gay Socials Turns One: 1st Birthday Celebration for Gay Men Who Want Real Connection
- Sea Fox® 368X "Extreme Edition" by Black Label Marine Group Celebrates 5 Years of the Commander Legacy
- CCHR Florida: Mental Health Awareness Month Open House
- Introducing LĪNA Universal Balm: A Luxury Multi-Use, Plant-Powered Solution for Skin & Hair
- UIFCA Revolutionizes Financial Education with Elite Team of Investment Experts
- Global Families Turn to Young Travelers Concierge Amid Rising Safety Concerns in the U.S
- Sober.Buzz the Sober Token : Ticker $BUZZ
- Divorce-Online Marks 25 Years Transforming Family Law Services in the UK
- Tampa-Based Digital Marketing Agency Launches New Website to Help Local Businesses Grow Online
- Meditech International Inc. and Los Angeles Rams Continue Strategic Partnership to Enhance Athlete Performance and Recovery
- myb.day Launches New Birthday Gift Shop Filled With Personalized Surprises
- DuoKey to Unveil Encrypted Financial Intelligence Use Case at GISEC Global 2025